National and international collaborations to accelerate advances in cancer research
The CRCM embodies a culture of transversality and multidisciplinarity creating bridges between fundamental, translational and clinical research.
These strategic alliances enable us to approach oncology from multiple angles and accelerate the development of innovative therapeutic solutions.
A strategic partnership with IPC and AP-HM
The CRCM relies on a strong collaboration with theInstitut Paoli-Calmettes (IPC) and the Assistance Publique - Hôpitaux de Marseille (AP-HM) a key partnership for translational research and innovation in oncology.
- Objective : Transforming scientific discoveries into concrete solutions for patients.
- Focus: Developing priority translational programs for breast cancer, pancreatic cancer and leukemia.
Multi-dimensional collaboration
CRCM strengthens its scientific impact through diversified partnerships with :
- Marseille Imaging and Institut Cancer & Immunologie.
- The Marseille Faculty of Pharmacy for training and innovation.
- Industrialists in molecular imaging, nano-vectorization and modern pharmacology, to transform discoveries into concrete therapies.
